Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Open Label Trial to Evaluate Radical Local Treatment Versus Palliative Treatment for Breast Cancer Patients With Ipsilateral Humerus or Sternum Oligometastasis

NCT04158843 is registered in ClinicalTrials.gov with xuexin he as lead sponsor.

NCT NCT04158843
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04158843 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Open Label Trial to Evaluate Radical Local Treatment Versus Palliative Treatment for Breast Cancer Patients With Ipsilateral Humerus or Sternum Oligometastasis
Lead sponsor
xuexin he
Phase
Not applicable
Overall status
Recruiting
Start date
May 9, 2020
Completion date
December 31, 2026
Enrollment
183 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, oligometastasis